about
DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.Genomic loss of the putative tumor suppressor gene E2A in human lymphoma.Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.Evaluation of T-cell clonality in archival skin biopsy samples of cutaneous T-cell lymphomas using the biomed-2 PCR protocol.The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma.The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell Lines.Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target.Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome.The tumour suppressor p53 is frequently nonfunctional in Sézary syndrome.Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand.Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.Mechanisms of targeting the MDM2-p53-FOXM1 axis in well-differentiated intestinal neuroendocrine tumors.Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.T-cell receptor gene rearrangement analysis of sequential biopsies in cutaneous T-cell lymphomas with the Biomed-2 PCR reveals transient T-cell clones in addition to the tumor clone.Molecular diagnostics in cutaneous lymphomas.Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling.[Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].Genome-Wide Analysis of Interchromosomal Interaction Probabilities Reveals Chained Translocations and Overrepresentation of Translocation Breakpoints in Genes in a Cutaneous T-Cell Lymphoma Cell Line.Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphomaT helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activityNext-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGSMutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto TrialZanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome
P50
Q30837199-26A58273-24A0-4A5F-942F-29D5744ABB58Q35136602-6E7F26CA-3229-4016-B5CE-21A17E274E75Q35144578-5699C7AC-46F7-4BBE-AFFA-21B6E7ED4F1FQ37262461-4AC87E18-137C-46D9-A299-9CA0DAFAA0A1Q37514725-BD6FB98D-0291-4F15-9885-A5B9AB27072AQ38416402-5D88FA94-DD3F-40F1-85F6-D390489FBD39Q38695102-277B2418-FB40-4648-8F21-3E7BE1D6DD8DQ38738828-5134CAD8-74AE-4A37-AC6D-E74AB0B160E9Q38784200-3776ED81-89CB-46ED-9BEC-E9724BA14E66Q38890130-B2DCF828-8827-40E7-B300-67B287B9E6F7Q38930782-30CAA7A3-B823-4F80-BE18-0BB3A79037BEQ39148599-A2AD5113-19C8-4124-9CC4-97E3AC60C298Q39386812-9BBCE20E-B23E-4F89-999D-5354A4E61901Q39455873-E5A97A68-EDFF-4819-BA28-27CF5E738B6BQ39533634-C98CA326-EBA4-4552-84E7-BA03C59B2053Q41945018-73175DF1-6AF3-4E13-9090-1B90D1B1A7FCQ47140422-798BE5FB-19C7-4433-96EC-EBA47BDA0298Q47984767-20B6088D-01F2-430C-81FF-B58A3B840B09Q50059039-8FDDA4FB-BC7A-44B8-A535-FD797B2134C5Q52876668-6D0D5B42-9454-4AE8-AC61-0F56AD174EEFQ52883768-20C02F44-F909-4398-A295-846DC1386CFBQ52888457-FA5AEAD3-2554-4F01-96C4-1CC6E9193E9FQ52888610-B8F37D98-F8D2-4333-94E2-F37BF0307255Q55089250-A115EAEC-D304-4AF7-B706-E90256130650Q56964639-D00D0B3E-8897-4D2E-9870-EC0A34D877C0Q61865938-5194C02A-262A-42A6-91D0-49355E2D3EC5Q92734201-48A27BA3-D41C-4D83-A991-5CDDC0628A0CQ93064583-2E5E73CC-327D-49DC-AB19-C7E056990D38Q94819870-76F9D77F-919A-49D3-BD7F-A96CCC072EC4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Markus Möbs
@ast
Markus Möbs
@en
Markus Möbs
@es
Markus Möbs
@nl
Markus Möbs
@sl
type
label
Markus Möbs
@ast
Markus Möbs
@en
Markus Möbs
@es
Markus Möbs
@nl
Markus Möbs
@sl
prefLabel
Markus Möbs
@ast
Markus Möbs
@en
Markus Möbs
@es
Markus Möbs
@nl
Markus Möbs
@sl
P106
P31
P496
0000-0002-1502-3032